InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Protecting life science patents in Latin America


Regimes for protecting pharmaceutical and biotechnological products via patents are slowly but steadily improving in many Latin American countries. Managing IP invited Alejandro Luna of Olivares & Ci­a, Guillermo Carey of HarneckerCarey Carey y Cía and in-house counsel Regina Kuchle to discuss some promising developments and continuing challenges

EM: What regulatory changes have most impacted biotechnology and pharmaceutical patents recently? AL: There was an amendment to the Mexican General Health Law in June 2009 which defined biotechnological drugs and allowed for the approval of follow-on biologics, or biocomparables. ...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

Federal Circuit rules in Amgen v Sandoz on remand from SCOTUS https://t.co/uYIkfVhCHG https://t.co/2OZAscsz32

Dec 14 2017 09:58 ·  reply ·  retweet ·  favourite
ManagingIP profile

RT @mdloney: Canada moves closer to joining the Hague Agreement with the release of proposed new Industrial Design Regulations https://t.co

Dec 12 2017 10:22 ·  reply ·  retweet ·  favourite
ManagingIP profile

ICYMI: our PTAB November round-up: filing slumps; tribal immunity briefs filed; Oil States and SAS argued; Aqua Pro… https://t.co/SXYidoVKEK

Dec 12 2017 10:04 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


null null null

null null null

End of Year 2017

Tribal sovereign immunity: Taking a wrecking ball to the IPR system

The lawyer behind Allergan’s controversial transfer of patents to a Native American tribe says others are “lining up to do deals”. But, Michael Loney asks, will the PTAB rule that sovereign immunity applies in these types of deals?



Most read articles

Supplements